Study uncovers critical roles for USP1 in Ewing sarcoma

A new research paper was published in Genes & Cancer on February 5, 2024, entitled, “Roles of USP1 in Ewing sarcoma.”

Enhertu Gets Tumor-Agnostic FDA Approval for HER2-Positive Cancers

The FDA granted tumor-agnostic accelerated approval to trastuzumab deruxtecan (Enhertu) for previously treated unresectable or metastatic HER2-positive (immunohistochemistry [IHC] 3+) solid cancers. The action represents

April 6, 2024

First U.S. case of new mpox strain detected in California

California has detected the country’s first case of a new mpox strain that is spreading from person to person. The infected individual had recently traveled

November 16, 2024

Study finds low and high GI diets boost endurance performance over low-carb diets

A study published in Sports Medicine – Open evaluated how carbohydrate intake and glycemic index affect endurance training outcomes, showing significant effects on metabolic flexibility

April 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.